Lawson Wilkins Pediatric Endocrine Society Banner
Policy Statements Seperator

Member Login Seperator
User Name: Password:
Forget your login?

 
Guidelines, Consensus Statements and Reviews
Seperator
These statements are provided by PES for reference and use by members. They represent statements sponsored by PES that the Society either initiated or was actively involved in developing.

Use of Bisphosphonates in the Treatment of Pediatric Osteoporosis (2011)
Use of Gonadotropin-Releasing Hormone Analogs in Children (2011)
Hyperglycemic Hyperosmolar Syndrome in Children: Pathophysiological Considerations and Suggested Guidelines for Treatment (2010)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (2009)
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association (2009)
ATA Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer (2009)
The Role of Recombinant Insulin-Like Growth Factor-I in Treating Children with Short Stature (2009)
Vitamin D Deficiency in Children and It Management: Review of Current Knowledge and Recommendations (2009)
Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature (2008)
Changes in Recombinant Human Growth Hormone (rhGH) Prescribing Information (2008)
Use of Aromatase Inhibitors in Children and Adolescents With Disorders of Growth and Adolescent Development (2007)
Increasing Minority Participation in Clinical Research ( 2007)
Adrenal Insufficiency ( 2007)
Consensus statement on management of intersex disorders (2006)
Insulin Infusion (2006)
Update of Newborn Screening and Therapy for Congenital Hypothyroidism (2006)
Childhood Obesity (2005)
Diabetic Ketoacidosis (2004)
Menstruation in Adolescent Females (2004)
Growth Hormone in Children (2003)
Consensus statement on 21- hydroxylase deficiency (2002)
Growth Hormone Treatment and Neoplasia (2002)
Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children